Company Registration No. 08799395 (England and Wales)
SURGICAL DYNAMICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SURGICAL DYNAMICS LIMITED
CONTENTS
Page
Company information
Balance sheet
1 - 2
Notes to the financial statements
3 - 10
SURGICAL DYNAMICS LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
344,465
593,285
Tangible assets
4
185,990
119,884
530,455
713,169
Current assets
Stocks
92,000
45,000
Debtors
5
63,752
99,426
Cash at bank and in hand
12,691
168,443
144,426
Creditors: amounts falling due within one year
6
(395,129)
(691,203)
Net current liabilities
(226,686)
(546,777)
Total assets less current liabilities
303,769
166,392
Creditors: amounts falling due after more than one year
7
(13,664)
(38,106)
Provisions for liabilities
(128,000)
Net assets
162,105
128,286
Capital and reserves
Called up share capital
8
125
125
Share premium account
19,975
19,975
Profit and loss reserves
142,005
108,186
Total equity
162,105
128,286
SURGICAL DYNAMICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025
31 December 2025
- 2 -
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 24 June 2026 and are signed on its behalf by:
Mr M B Jessup
Director
Company registration number 08799395 (England and Wales)
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
Surgical Dynamics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 35A, Werdohl Way, Number One Industrial Estate, Consett, Co Durham, DH8 6SZ.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets comprise primarily patent fees regarding patents registered in various countries for certain products and development costs. Developments cost are released once the product has gone into production.
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents
20 years
Development Costs
5 years
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
over 3 years
Plant and machinery
15% reducing balance
Fixtures & fittings
15% reducing balance
Computer equipment
20% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.8
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.10
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.11
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.12
Taxation
The tax expense represents the sum of the tax currently payable.
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
1.13
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
1.14
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.15
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.16
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
11
7
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
3
Intangible fixed assets
Patents
Development Costs
Total
£
£
£
Cost
At 1 January 2025 and 31 December 2025
58,668
1,116,116
1,174,784
Amortisation and impairment
At 1 January 2025
39,175
542,324
581,499
Amortisation charged for the year
1,357
47,463
48,820
Impairment losses
200,000
200,000
At 31 December 2025
40,532
789,787
830,319
Carrying amount
At 31 December 2025
18,136
326,329
344,465
At 31 December 2024
19,493
573,792
593,285
4
Tangible fixed assets
Leasehold improvements
Plant and machinery
Fixtures & fittings
Computer equipment
Total
£
£
£
£
£
Cost
At 1 January 2025
20,032
308,981
3,719
10,208
342,940
Additions
74,039
8,090
82,129
Disposals
(20,032)
(34,145)
(3,719)
(10,208)
(68,104)
At 31 December 2025
348,875
8,090
356,965
Depreciation and impairment
At 1 January 2025
20,032
190,057
3,030
9,937
223,056
Depreciation charged in the year
19,464
421
19,885
Eliminated in respect of disposals
(20,032)
(38,967)
(3,030)
(9,937)
(71,966)
At 31 December 2025
170,554
421
170,975
Carrying amount
At 31 December 2025
178,321
7,669
185,990
At 31 December 2024
118,924
689
271
119,884
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
41,593
78,191
Other debtors
22,159
21,235
63,752
99,426
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
3,106
16,567
Obligations under finance leases
13,333
13,333
Other borrowings
8,400
324,855
Trade creditors
39,508
36,426
Taxation and social security
32,238
64,945
Other creditors
137,425
229,906
Accruals and deferred income
161,119
5,171
395,129
691,203
7
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
6,658
9,377
Obligations under finance leases
13,333
Other borrowings
7,006
15,396
13,664
38,106
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
A Ordinary shares of £1 each
25
25
25
25
125
125
125
125
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
8
Called up share capital
(Continued)
- 9 -
All shares have equal voting rights.
A Ordinary shares have the right to a dividend equal to 8% of the net profits for any financial year, payable within 4 months of the year end. Interest will accrue at 4% over the base rate on any late payment of dividend. After payment of this dividend ordinary shares have the right to an equal amount of dividends, providing that there are sufficient reserves. Subsequent to this both class of shares have an equal right to dividends.
On liquidation, capital reduction or otherwise, any outstanding dividends due to A Ordinary shareholders are paid first with A Ordinary shareholders then receiving repayment of their capital and share premium balance before any other shareholders are paid.
9
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
27,972
30,641
10
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
2025
2024
Amounts due to related parties
£
£
M & C Jessup (directors)
-
39,719
W Wang (director)
64,718
159,104
The directors have provided personal guarantees and pledged personal security against some of the loans totalling £15,406 (2024: £129,973).
SURGICAL DYNAMICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
10
Related party transactions
(Continued)
- 10 -
Interest free loans have been granted by the company to its directors as follows:
2025
2024
Amounts due from related parties
£
£
M & C Jessup (directors)
31,852
-
2025-12-312025-01-01falsefalsefalse24 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMrs Patricia JessupMr Mark JessupDr Wanqi WangMrs P C Jessup087993952025-01-012025-12-31087993952025-12-31087993952024-12-3108799395core:PatentsTrademarksLicencesConcessionsSimilar2025-12-3108799395core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-3108799395core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3108799395core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3108799395core:LeaseholdImprovements2025-12-3108799395core:PlantMachinery2025-12-3108799395core:FurnitureFittings2025-12-3108799395core:ComputerEquipment2025-12-3108799395core:LeaseholdImprovements2024-12-3108799395core:PlantMachinery2024-12-3108799395core:FurnitureFittings2024-12-3108799395core:ComputerEquipment2024-12-3108799395core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3108799395core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3108799395core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3108799395core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3108799395core:Non-currentFinancialInstruments2025-12-3108799395core:Non-currentFinancialInstruments2024-12-3108799395core:ShareCapital2025-12-3108799395core:ShareCapital2024-12-3108799395core:SharePremium2025-12-3108799395core:SharePremium2024-12-3108799395core:RetainedEarningsAccumulatedLosses2025-12-3108799395core:RetainedEarningsAccumulatedLosses2024-12-3108799395core:ShareCapitalOrdinaryShareClass12025-12-3108799395core:ShareCapitalOrdinaryShareClass12024-12-3108799395core:ShareCapitalOrdinaryShareClass22025-12-3108799395core:ShareCapitalOrdinaryShareClass22024-12-3108799395core:ShareCapitalOrdinaryShares2025-12-3108799395core:ShareCapitalOrdinaryShares2024-12-3108799395bus:Director12025-01-012025-12-3108799395core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3108799395core:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3108799395core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-012025-12-3108799395core:LeaseholdImprovements2025-01-012025-12-3108799395core:PlantMachinery2025-01-012025-12-3108799395core:FurnitureFittings2025-01-012025-12-3108799395core:ComputerEquipment2025-01-012025-12-31087993952024-01-012024-12-3108799395core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3108799395core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31087993952024-12-3108799395core:LeaseholdImprovements2024-12-3108799395core:PlantMachinery2024-12-3108799395core:FurnitureFittings2024-12-3108799395core:ComputerEquipment2024-12-3108799395core:CurrentFinancialInstruments2025-12-3108799395core:CurrentFinancialInstruments2024-12-3108799395bus:OrdinaryShareClass12025-01-012025-12-3108799395bus:OrdinaryShareClass22025-01-012025-12-3108799395bus:OrdinaryShareClass12025-12-3108799395bus:OrdinaryShareClass12024-12-3108799395bus:OrdinaryShareClass22025-12-3108799395bus:OrdinaryShareClass22024-12-3108799395bus:AllOrdinaryShares2025-12-3108799395bus:AllOrdinaryShares2024-12-3108799395bus:PrivateLimitedCompanyLtd2025-01-012025-12-3108799395bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108799395bus:FRS1022025-01-012025-12-3108799395bus:AuditExemptWithAccountantsReport2025-01-012025-12-3108799395bus:Director22025-01-012025-12-3108799395bus:Director32025-01-012025-12-3108799395bus:CompanySecretary12025-01-012025-12-3108799395bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP